SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-14-000333
Filing Date
2014-03-04
Accepted
2014-03-04 15:18:45
Documents
8
Period of Report
2014-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 10974
2 PROXY MATERIALS ex991.htm EX-99.1 391595
3 FORM OF PROXY ex992.htm EX-99.2 1122
4 GRAPHIC image_001.jpg GRAPHIC 5502
5 GRAPHIC image_002.jpg GRAPHIC 359127
6 GRAPHIC image_003.jpg GRAPHIC 241519
7 GRAPHIC image_004.jpg GRAPHIC 37683
8 GRAPHIC image_005.jpg GRAPHIC 20201
  Complete submission text file 0001279569-14-000333.txt   1320505
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 14664322
SIC: 2836 Biological Products, (No Diagnostic Substances)